NHI — National Health Investors Cashflow Statement
0.000.00%
- $3.70bn
- $4.97bn
- $375.63m
Annual cashflow statement for National Health Investors, fiscal year end - December 31st, USD millions except per share, conversion factor applied.
2021 December 31st | 2022 December 31st | 2023 December 31st | 2024 December 31st | 2025 December 31st | |
|---|---|---|---|---|---|
| Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
| Source: | 10-K | 10-K | 10-K | 10-K | 10-K |
| Standards: | USG | USG | USG | USG | USG |
| Status: | Final | Final | Final | Final | Final |
| Net Income/Starting Line | 112 | 65.5 | 134 | 137 | 141 |
| Depreciation | |||||
| Non-Cash Items | 14.5 | 48.1 | -25.9 | -2.46 | 7.63 |
| Unusual Items | |||||
| Equity in Net Earnings/Losses | |||||
| Other Non-Cash Items | |||||
| Changes in Working Capital | 3.61 | 0.837 | 6.03 | 2.15 | 7.2 |
| Change in Payable / Accrued Expenses | |||||
| Change in Other Liabilities | |||||
| Cash from Operating Activities | 211 | 185 | 184 | 208 | 237 |
| Capital Expenditures | -50.3 | -11 | -49.6 | -158 | -294 |
| Purchase of Fixed Assets | |||||
| Other Investing Cash Flow Items | 236 | 209 | 37.9 | -34.4 | 24.9 |
| Sale of Fixed Assets | |||||
| Purchase of Investments | |||||
| Other Investing Cash Flow | |||||
| Cash from Investing Activities | 185 | 198 | -11.6 | -192 | -269 |
| Financing Cash Flow Items | -7.39 | 5.86 | -1.05 | -10.2 | -4.28 |
| Other Financing Cash Flow | |||||
| Total Cash Dividends Paid | |||||
| Net Issuance / Retirement of Stock | |||||
| Net Issuance / Retirement of Debt | |||||
| Cash from Financing Activities | -403 | -401 | -170 | -13.6 | 25.7 |
| Beginning Cash Balance | |||||
| Ending Cash Balance | |||||
| Net Change in Cash | -6.86 | -18 | 3.1 | 1.89 | -6.88 |